117 related articles for article (PubMed ID: 18177798)
1. Clinical impact of molecular analysis on thyroid cancer management.
Wreesmann VB; Singh B
Surg Oncol Clin N Am; 2008 Jan; 17(1):1-35, vii. PubMed ID: 18177798
[TBL] [Abstract][Full Text] [Related]
2. Anaplastic transformation of thyroid cancer: review of clinical, pathologic, and molecular evidence provides new insights into disease biology and future therapy.
Wiseman SM; Loree TR; Rigual NR; Hicks WL; Douglas WG; Anderson GR; Stoler DL
Head Neck; 2003 Aug; 25(8):662-70. PubMed ID: 12884350
[TBL] [Abstract][Full Text] [Related]
3. Clinical implications of molecular markers in follicular cell-derived thyroid cancer.
Pinto AE; Leite V; Soares J
Expert Rev Mol Diagn; 2009 Oct; 9(7):679-94. PubMed ID: 19817553
[TBL] [Abstract][Full Text] [Related]
4. New therapeutic advances in the management of progressive thyroid cancer.
Woyach JA; Shah MH
Endocr Relat Cancer; 2009 Sep; 16(3):715-31. PubMed ID: 19218279
[TBL] [Abstract][Full Text] [Related]
5. Thyroid cancer: the impact of emerging technologies on clinical practice guidelines.
Mechanick JI; Carpi A
Biomed Pharmacother; 2008 Oct; 62(8):554-8. PubMed ID: 18752920
[TBL] [Abstract][Full Text] [Related]
6. Genetic mutations in thyroid carcinoma.
Taccaliti A; Boscaro M
Minerva Endocrinol; 2009 Mar; 34(1):11-28. PubMed ID: 19209125
[TBL] [Abstract][Full Text] [Related]
7. Treatment of recurrent thyroid cancers--is there a light in the horizon?
Rovere RK; Awada A
Curr Opin Oncol; 2008 May; 20(3):245-8. PubMed ID: 18391621
[TBL] [Abstract][Full Text] [Related]
8. Current management of medullary thyroid cancer.
Sippel RS; Kunnimalaiyaan M; Chen H
Oncologist; 2008 May; 13(5):539-47. PubMed ID: 18515739
[TBL] [Abstract][Full Text] [Related]
9. Cytogenetic and molecular aspects of gastric cancer: clinical implications.
Panani AD
Cancer Lett; 2008 Aug; 266(2):99-115. PubMed ID: 18381231
[TBL] [Abstract][Full Text] [Related]
10. Poorly differentiated thyroid cancer.
Patel KN; Shaha AR
Curr Opin Otolaryngol Head Neck Surg; 2014 Apr; 22(2):121-6. PubMed ID: 24492853
[TBL] [Abstract][Full Text] [Related]
11. Expression and mutation analysis of the tyrosine kinase c-kit in poorly differentiated and anaplastic thyroid carcinoma.
Broecker-Preuss M; Sheu SY; Worm K; Feldkamp J; Witte J; Scherbaum WA; Mann K; Schmid KW; Schott M
Horm Metab Res; 2008 Oct; 40(10):685-91. PubMed ID: 18622894
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylated insulin like growth factor-I receptor expression and its clinico-pathological significance in histologic subtypes of human thyroid cancer.
Chakravarty G; Santillan AA; Galer C; Adams HP; El-Naggar AK; Jasser SA; Mohsin S; Mondal D; Clayman GL; Myers JN
Exp Biol Med (Maywood); 2009 Apr; 234(4):372-86. PubMed ID: 19176870
[TBL] [Abstract][Full Text] [Related]
13. [Fetal cell carcinogenesis hypothesis and its impact on clinical pathology of cancer].
Takano T
Rinsho Byori; 2008 May; 56(5):402-8. PubMed ID: 18546890
[TBL] [Abstract][Full Text] [Related]
14. Selective surgical management of well-differentiated thyroid cancer.
Shaha A
Ann N Y Acad Sci; 2008 Sep; 1138():58-64. PubMed ID: 18837884
[TBL] [Abstract][Full Text] [Related]
15. Aneuploidy and high S-phase as biomarkers of poor clinical outcome in poorly differentiated and anaplastic thyroid carcinoma.
Pinto AE; Silva G; Banito A; Leite V; Soares J
Oncol Rep; 2008 Oct; 20(4):913-9. PubMed ID: 18813835
[TBL] [Abstract][Full Text] [Related]
16. Thyroid cancer genetics: multiple endocrine neoplasia type 2, non-medullary familial thyroid cancer, and familial syndromes associated with thyroid cancer.
Richards ML
Surg Oncol Clin N Am; 2009 Jan; 18(1):39-52, viii. PubMed ID: 19056041
[TBL] [Abstract][Full Text] [Related]
17. Unusual tumors of the thyroid gland.
Baloch ZW; LiVolsi VA
Endocrinol Metab Clin North Am; 2008 Jun; 37(2):297-310, vii. PubMed ID: 18502328
[TBL] [Abstract][Full Text] [Related]
18. Gal-3 is stimulated by gain-of-function p53 mutations and modulates chemoresistance in anaplastic thyroid carcinomas.
Lavra L; Ulivieri A; Rinaldo C; Dominici R; Volante M; Luciani E; Bartolazzi A; Frasca F; Soddu S; Sciacchitano S
J Pathol; 2009 May; 218(1):66-75. PubMed ID: 19199318
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis, treatment, prognostic factors and long-term outcome in papillary thyroid carcinoma.
Pelizzo MR; Merante Boschin I; Toniato A; Pagetta C; Casal Ide E; Mian C; Rubello D
Minerva Endocrinol; 2008 Dec; 33(4):359-79. PubMed ID: 18923371
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of the mitotic spindle assembly checkpoint genes hBUB1, hBUBR1 and hMAD2 in thyroid carcinomas with aggressive nature.
Wada N; Yoshida A; Miyagi Y; Yamamoto T; Nakayama H; Suganuma N; Matsuzu K; Masudo K; Hirakawa S; Rino Y; Masuda M; Imada T
Anticancer Res; 2008; 28(1A):139-44. PubMed ID: 18383837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
